Junjiang Sun

Author PubWeight™ 9.07^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Optimization of self-complementary AAV vectors for liver-directed expression results in sustained correction of hemophilia B at low vector dose.	Mol Ther	2007	1.85
2	Cellular immune response to cryptic epitopes during therapeutic gene transfer.	Proc Natl Acad Sci U S A	2009	1.53
3	Proteasome inhibitors enhance gene delivery by AAV virus vectors expressing large genomes in hemophilia mouse and dog models: a strategy for broad clinical application.	Mol Ther	2010	1.24
4	Glycan binding avidity determines the systemic fate of adeno-associated virus type 9.	J Virol	2012	1.05
5	Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trial.	Hum Gene Ther	2015	0.97
6	NIM811 prevents mitochondrial dysfunction, attenuates liver injury, and stimulates liver regeneration after massive hepatectomy.	Transplantation	2011	0.94
7	VHL and PTEN loss coordinate to promote mouse liver vascular lesions.	Angiogenesis	2010	0.85
8	Hemophilic synovitis: factor VII and the potential role of extravascular factor VIIa.	Thromb Res	2010	0.75